Attenuation of ischemia - Reperfusion injury by enalapril maleat

General Pharmacology

Volumn 31, Issue 2, 1998, Pages 203-208

  Doǧan, Riza ^a   Farsak, Bora ^a   Tuncer, Meltem ^a   Demirpençe, Ediz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cardioplegic arrest; Enalapril maleat; Lipid peroxidation; Myocardial ischemia; Myocardial protection

Indexed keywords

CREATINE KINASE; ENALAPRIL MALEATE; ST THOMAS HOSPITAL SOLUTION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; GUINEA PIG; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; ISOLATED HEART; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REPERFUSION INJURY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOPLEGIC SOLUTIONS; DRUG EVALUATION, PRECLINICAL; ENALAPRIL; GUINEA PIGS; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL REPERFUSION INJURY;

EID: 0344404314     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00010-X     Document Type: Article

References (44)

1. Bagchi D., Iyengar J., Stockwell P. and Das D. K. (1989) Enhanced prostaglandin production in the ischemic reperfused myocardium by captopril linked with its free radical scavenging action. Prostaglandins Leukot. Essent. Fatty Acids 38, 145-150.
2. Baumgarten C. R., Linz W., Kunkel G., Scholkens B. A. and Wiemer G. (1993) Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br. J. Pharmac. 108, 293-295.
3. Braunwald E. and Kloner R. A. (1989) The stunned myocardium prolonged, post-ischemic ventricular dysfunction. Circulation 66, 1146-1149.
4. Burtis C. A. and Ashwood E. R. (1994) Determination of lactate in whole blood. In Clinical Chemistry (Edited by Tietz), pp. 976-978. Saunders, Philadelphia.
5. Cargnoni A., Boraso A., Scatti C., Ghirardelli N., Benigno M., Bernocchi P., Pedersini P. and Ferrari R. (1994) Effect of angiotension converting enzyme inhibitors with quinaprilat on the ischemic and reperfused myocardium. J. Mol. Cell. Cardiol. 9, 69-86.
6. Cohen M. V. (1989) Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials? Ann. Int. Med. 11, 921-931.
7. Comporti M. (1987) Glutathione depleting agents and lipid peroxidation. Chem. Phys. Lipids 45, 143-169.
8. Coretti M. C., Koretsune Y., Kusuoka H., Chacko V. P., Zweir J. L. and Marban E. (1991) Glycolytic inhibition and calcium overload as consequences of exogeneously generated free radicals in rabbit hearts. J. Clin. Invest. 88, 1014-1025.
9. De Graeff P. A., Van Gilst W. H., Bel K., Langen C. D. J., Kingma J. H. and Wesseling H. (1987) Concentration dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model. J. Cardiovasc. Pharmac. 9(Suppl. 2), 37-42.
10. Di Napoli P., Di Gregorio G., Di Sanctis F., Gallina S. and Di Girolamo E. (1993) The myocardial protective effects of cardiac tissue ACE inhibition in experimental ischemia-reperfusion in isolated rat heart. Cardioplegia 38, 107-112.
11. Di Pasquale P., Paterna S., Valanza M., Valdes L., Albano V., Trombino G., Vitrano G., Cannizzaro S., Licata G. and Albiero R. (1993) Effects of captopril on myocardial protection during cardioplegia. Int. J. Cardiol. 42, 225-230.
12. Drummer O. F., Routley L. and Christophidis N. (1987) Reversibility of disulfide formation: comparison of chemical and enzyme mediated reduction of penicillamin and captopril disulfides. Biochem. Pharmac. 36, 1197-1203.
13. Ertl G. (1988) Angiotensin converting enzyme inhibitors and ischemic heart disease. Eur. Heart. J. 9, 716-727.
14. Ertl G., Kloner R. A., Alexander R. W. and Braunwald E. (1982) Limitation of experimental infarct size by an angiotensin converting enzyme inhibitor. Circulation 65, 40-48.
15. Ferrari R., Ceconi C. and Curello S. (1985) Oxygen-mediated myocardial damage during ischemia and reperfusion: role of the cellular defences against oxygen toxicity. J. Mol. Cell. Cardiol. 17, 937-945.
16. Ferrari R., Cargnoni A., Curello S., Ceconi C., Boraso A. and Visioli O. (1992) Protection of the ischemic myocardium by converting-enzyme inhibitor zefenopril: insight into its mechanism of action. J. Cardiovasc. Pharmac. 20, 694-704.
17. Ferrari R., Ceconi C., Curello S., Alfieri O. and Visioli O. (1993) Myocardial damage during ischemia and reperfusion. Eur. Heart J. 14(Suppl. G), 25-30.
18. Flitter W. D. (1993) Free radicals and myocardial reperfusion injury. Br. Med. Bull. 49, 545-555.
19. Freeman B. A. and Crapo J. D. (1982) Biology of disease free radicals and tissue injury. Lab. Invest. 47, 412-426.
20. Gardner T. J., Stewart J. R., Casale A. S., Downey J. M. and Chambers D. E. (1983) Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery 94, 423-427.
21. Gauduel Y. and Duvelleroy M. A. (1984) Role of oxygen radicals in cardiac injury due to reoxygenation. J. Mol. Cell. Cardiol. 16, 459-470.
22. Grover G. G., Sleph P. G., Dzwonczyk S., Wang P., Fung W., Tobias D. and Cushman D. W. (1991) Effects of different angiotensin converting enzyme inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. 257, 919-929.
23. Guarnieri C., Flamigni F. and Caldarela C. M. (1980) Role of oxygen in the cellular damage induced by reoxygenation of the hypoxic heart. J. Mol. Cell. Cardiol. 12, 797-808.
24. Hearse D. J. (1990) Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc. Drugs Ther. 4, 767-776.
25. Hess M. L. and Manson N. H. (1984) Molecular oxygen - friend and foe: the role of oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 16, 969-985.
26. Hock C. E., Ribeiro L. G. and Lefer A. M. (1985) Preservation of ischemic myocardium by a new converting enzyme inhibitor, enaprilic acid, in acute myocardial infarction. Am. Heart J. 109, 222-228.
27. Jimenez E., del Nido P., Feinberg H. and Levitsky S. (1993) Redistribution of myocardial calcium during ischemia: relationship to onset of contracture. J. Thorac. Cardiovasc. Surg. 105, 988-993.
28. Johnston C. L., Clappison B. H., Anderson W. P. and Yasujima M. (1982) Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am. J. Cardiol. 49, 1401-1404.
29. Jong J. W. D. and Goldstein S. (1974) Changes in coronary venous inosine concentration and myocardial wall thickening during regional ischemia in the pig. Circ. Res. 35, 111-116.
30. Koerner J. A., Anderson B. A. and Dage R. C. (1991) Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen derived free radicals: superoxide dismutase plus catalase, N-2 mercaptopropionyl glycine and captopril. J. Cardiovasc. Pharmac. 17, 185-191.
31. Kukreja R. C., Kontos H. A. and Hess M. L. (1990) Captopril and enaprilat do not scavenge the superoxide anion. Am. J. Cardiol. 65, 241-271.
32. Lefer A. M. and Peck R. C. (1984) Cardioprotective effects of captopril in acute myocardial ischemia. Pharmacology 29, 61-64.
33. Martorana P. A., Kettenbach B., Briephol G., Linz W. and Scholkens B. A. (1990) Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur. J. Pharmac. 182, 395-396.
34. McCord J. M. (1985) Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159-163.
35. Menasche P., Grousset C., Peynet J., Mouas C., Bloch G. and Piwnica A. (1992) Pretreatment with captopril improves myocardial recovery after cardioplegic arrest. J. Cardiovasc. Pharmac. 19, 402-407.
36. Murthy V. S., Waldron T. L. and Goldberg M. E. (1978) The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme by SQ 14, 225 in conscious rabbits. Circ. Res. 43(Suppl. 1), 140-145.
37. Prasad K., Kalra J., Chan W. P. and Chaudhary A. K. (1989) Effect of oxygen free radicals on cardiovascular function at organ and cellular level. Am. Heart J. 117, 1196-1202.
38. Prasad K., Kalra J., Bharadwaj B. and Chaudhary A. K. (1992) Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am. Heart J. 123, 37-45.
39. Schwartz S. L. and Williams G. H. (1982) Angiotensin converting enzyme inhibition and prostaglandins. Am. J. Cardiol. 49, 1405-1409.
40. Shattock M. J. and Matsuura H. (1993) Measurement of sodium potassium pump current in isolated rabbit ventricular myocyte using the whole cells voltage clamp technique: inhibition of the pump by oxidant stress. Circ. Res. 72, 91-101.
41. Shlafer M., Kane P. F., Wiggins V. Y. and Kirsh M. M. (1982) Possible role of cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury. Circulation 66(Suppl. 1), 85-92.
42. Uchiyama M. and Mihara M. (1977) Determination of malonlaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 4, 271-278.
43. Van Gilst W. H., De Graeff T. A., Wesseling H. and Langen C. D. J. (1986) Reduction of reperfusion arrhythmia in the ischemic isolated rat heart by angiotensin-converting enzyme inhibitors: a comparison of captopril, enapril and HOE 8. J. Cardiovasc. Pharmac. 8, 722-728.
44. Westlin W. and Mullane K. (1988) Does captopril attenuate reperfusion induced myocardial dysfunction by scavenging free radicals? Circulation 77(Suppl. 1), 130-139.